Corrigendum: Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis
Silvia Tenembaum1 
E. Ann Yeh2* The Guthy-Jackson Foundation International Clinical Consortium (GJCF-ICC)†- 1Department of Neurology, National Pediatric Hospital Dr. J. Garrahan, Buenos Aires, Argentina
- 2Division of Neurology, Department of Pediatrics, SickKids Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
A Corrigendum on
Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis
by Tenembaum, S., Yeh, E. A., and The Guthy-Jackson Foundation International Clinical Consortium (GJCF-ICC) (2020). Front. Pediatr. 8:339. doi: 10.3389/fped.2020.00339
In the original article, there was a mistake in Table 3 as published. The administration form of satralizumab is “SC” not “IV.” The corrected Table 3 appears below.
Table 3. Immunosuppressive molecules for attack prevention in NMOSD.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: pediatric, neuroinflammation, NMOSD, MOG, treatment, diagnosis
Citation: Tenembaum S, Yeh EA and The Guthy-Jackson Foundation International Clinical Consortium (GJCF-ICC) (2021) Corrigendum: Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis. Front. Pediatr. 8:642203. doi: 10.3389/fped.2020.642203
Received: 15 December 2020; Accepted: 16 December 2020;
Published: 15 February 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Tenembaum, Yeh and The Guthy-Jackson Foundation International Clinical Consortium (GJCF-ICC). This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: E. Ann Yeh, ann.yeh@sickkids.ca
†See Appendix for complete list of active GJCF-ICC Members